172 related articles for article (PubMed ID: 12727882)
1. Recruitment of human cyclin T1 to nuclear bodies through direct interaction with the PML protein.
Marcello A; Ferrari A; Pellegrini V; Pegoraro G; Lusic M; Beltram F; Giacca M
EMBO J; 2003 May; 22(9):2156-66. PubMed ID: 12727882
[TBL] [Abstract][Full Text] [Related]
2. Functional inactivation of Cdk9 through oligomerization chain reaction.
Napolitano G; Mazzocco A; Fraldi A; Majello B; Lania L
Oncogene; 2003 Jul; 22(31):4882-8. PubMed ID: 12894230
[TBL] [Abstract][Full Text] [Related]
3. Visualization of in vivo direct interaction between HIV-1 TAT and human cyclin T1 in specific subcellular compartments by fluorescence resonance energy transfer.
Marcello A; Cinelli RA; Ferrari A; Signorelli A; Tyagi M; Pellegrini V; Beltram F; Giacca M
J Biol Chem; 2001 Oct; 276(42):39220-5. PubMed ID: 11504720
[TBL] [Abstract][Full Text] [Related]
4. The Cdk9 and cyclin T subunits of TAK/P-TEFb localize to splicing factor-rich nuclear speckle regions.
Herrmann CH; Mancini MA
J Cell Sci; 2001 Apr; 114(Pt 8):1491-503. PubMed ID: 11282025
[TBL] [Abstract][Full Text] [Related]
5. PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia.
Boddy MN; Howe K; Etkin LD; Solomon E; Freemont PS
Oncogene; 1996 Sep; 13(5):971-82. PubMed ID: 8806687
[TBL] [Abstract][Full Text] [Related]
6. An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation.
Suñé C; Goldstrohm AC; Peng J; Price DH; Garcia-Blanco MA
Virology; 2000 Sep; 274(2):356-66. PubMed ID: 10964778
[TBL] [Abstract][Full Text] [Related]
7. Promyelocytic leukemia protein PML inhibits Nur77-mediated transcription through specific functional interactions.
Wu WS; Xu ZX; Ran R; Meng F; Chang KS
Oncogene; 2002 May; 21(24):3925-33. PubMed ID: 12032831
[TBL] [Abstract][Full Text] [Related]
8. Role of the promyelocytic leukemia body in the dynamic interaction between the androgen receptor and steroid receptor coactivator-1 in living cells.
Rivera OJ; Song CS; Centonze VE; Lechleiter JD; Chatterjee B; Roy AK
Mol Endocrinol; 2003 Jan; 17(1):128-40. PubMed ID: 12511612
[TBL] [Abstract][Full Text] [Related]
9. Regulatory functions of Cdk9 and of cyclin T1 in HIV tat transactivation pathway gene expression.
Romano G; Kasten M; De Falco G; Micheli P; Khalili K; Giordano A
J Cell Biochem; 1999 Dec; 75(3):357-68. PubMed ID: 10536359
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional activation of the cyclin-dependent kinase inhibitor p21 by PML/RARalpha.
Yang WL; Zeng YX; El-Deiry WS; Nason-Burchenal K; Dmitrovsky E; Chin KV
Mol Cell Biol Res Commun; 1999 May; 1(2):125-31. PubMed ID: 10356361
[TBL] [Abstract][Full Text] [Related]
11. Human-herpesvirus-8-encoded K8 protein colocalizes with the promyelocytic leukemia protein (PML) bodies and recruits p53 to the PML bodies.
Katano H; Ogawa-Goto K; Hasegawa H; Kurata T; Sata T
Virology; 2001 Aug; 286(2):446-55. PubMed ID: 11485412
[TBL] [Abstract][Full Text] [Related]
12. Cyclin T1 domains involved in complex formation with Tat and TAR RNA are critical for tat-activation.
Ivanov D; Kwak YT; Nee E; Guo J; García-Martínez LF; Gaynor RB
J Mol Biol; 1999 Apr; 288(1):41-56. PubMed ID: 10329125
[TBL] [Abstract][Full Text] [Related]
13. Distinct nuclear body components, PML and SMRT, regulate the trans-acting function of HTLV-1 Tax oncoprotein.
Ariumi Y; Ego T; Kaida A; Matsumoto M; Pandolfi PP; Shimotohno K
Oncogene; 2003 Mar; 22(11):1611-9. PubMed ID: 12642864
[TBL] [Abstract][Full Text] [Related]
14. Metabolic-energy-dependent movement of PML bodies within the mammalian cell nucleus.
Muratani M; Gerlich D; Janicki SM; Gebhard M; Eils R; Spector DL
Nat Cell Biol; 2002 Feb; 4(2):106-10. PubMed ID: 11753375
[TBL] [Abstract][Full Text] [Related]
15. PML bodies control the nuclear dynamics and function of the CHFR mitotic checkpoint protein.
Daniels MJ; Marson A; Venkitaraman AR
Nat Struct Mol Biol; 2004 Nov; 11(11):1114-21. PubMed ID: 15467728
[TBL] [Abstract][Full Text] [Related]
16. FBI-1 can stimulate HIV-1 Tat activity and is targeted to a novel subnuclear domain that includes the Tat-P-TEFb-containing nuclear speckles.
Pendergrast PS; Wang C; Hernandez N; Huang S
Mol Biol Cell; 2002 Mar; 13(3):915-29. PubMed ID: 11907272
[TBL] [Abstract][Full Text] [Related]
17. The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA.
Lai HK; Borden KL
Oncogene; 2000 Mar; 19(13):1623-34. PubMed ID: 10763819
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation by targeted recruitment of cyclin-dependent CDK9 kinase in vivo.
Majello B; Napolitano G; Giordano A; Lania L
Oncogene; 1999 Aug; 18(32):4598-605. PubMed ID: 10467404
[TBL] [Abstract][Full Text] [Related]
19. Functional interaction between cyclin T1/cdk9 and Puralpha determines the level of TNFalpha promoter activation by Tat in glial cells.
Darbinian N; Sawaya BE; Khalili K; Jaffe N; Wortman B; Giordano A; Amini S
J Neuroimmunol; 2001 Dec; 121(1-2):3-11. PubMed ID: 11730934
[TBL] [Abstract][Full Text] [Related]
20. Regulation of p53 activity in nuclear bodies by a specific PML isoform.
Fogal V; Gostissa M; Sandy P; Zacchi P; Sternsdorf T; Jensen K; Pandolfi PP; Will H; Schneider C; Del Sal G
EMBO J; 2000 Nov; 19(22):6185-95. PubMed ID: 11080164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
